Bank of New York Mellon’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-71,993
Closed -$541K 4733
2022
Q1
$541K Buy
71,993
+30
+0% +$248 ﹤0.01% 3664
2021
Q4
$1.01M Buy
71,963
+1,561
+2% +$30.8K ﹤0.01% 3383
2021
Q3
$1.82M Buy
70,402
+6,206
+10% +$197K ﹤0.01% 3040
2021
Q2
$2.94M Sell
64,196
-2,625
-4% -$124K ﹤0.01% 2765
2021
Q1
$2.94M Buy
66,821
+18,706
+39% +$910K ﹤0.01% 2702
2020
Q4
$1.48M Buy
48,115
+16,024
+50% +$508K ﹤0.01% 3020
2020
Q3
$1.02M Buy
+32,091
New +$788K ﹤0.01% 3115

Other funds holding AMTI

Bank of New York Mellon's AMTI Position: Q2 2022 in Review

Bank of New York Mellon sold out of Applied Molecular Transport Inc. Common Stock (AMTI) in Q2 2022, closing a stake of 71,993 shares — an estimated $541K sold.

Bank of New York Mellon first reported a position in AMTI in Q3 2020 and held it in 7 quarters. The position peaked at $2.94M in Q1 2021. 56 funds tracked by Wall St. Rank hold AMTI as of Q2 2022.

  • Bank of New York Mellon reported no remaining Applied Molecular Transport Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Bank of New York Mellon sold 71,993 Applied Molecular Transport Inc. Common Stock shares in Q2 2022, an estimated $541K.
  • Bank of New York Mellon first reported a position in Applied Molecular Transport Inc. Common Stock in Q3 2020 and held it in 7 quarters.
  • Bank of New York Mellon's Applied Molecular Transport Inc. Common Stock position peaked at $2.94M in Q1 2021.
  • 56 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q2 2022.

Based on Bank of New York Mellon's 13F filing for Q2 2022, filed 15 Aug 2022.